A UAB researcher focusing on the epigenetics of drug abuse wins a significant funding award from the National Institutes of Health.
New research identifies an epigenetic cause for why patients with temporal lobe epilepsy tend to have memory loss, and suggests a potential way to reverse that loss.
David Sweatt, Ph.D., the Evelyn F. McKnight Endowed Chairman of the Department of Neurobiology, has been appointed interim director of the UAB Civitan International Research Center, effective June 1.
UAB researchers find a chemical pathway — a glutamate transporter — that may be causing seizures and shorten survival rates for patients with brain tumors.
Three School of Medicine faculty members were honored last week as recipients of the 2015 UAB Graduate School Dean’s Awards for Excellence in Mentorship.
A new comprehensive textbook on neurological diseases and conditions from the desk of a UAB neuroscientist will be available this spring.
J. David Sweatt, Ph.D., chair of the Department of Neurobiology, will speak about the epigenetic mechanisms in memory formation at the National Institutes of Health campus on March 13.
The Neuroscience Roadmap Scholars Program is designed to help graduate students from underrepresented communities — racial/ethnic minorities and people with disability — succeed in a career in neuroscience.
Research into rare diseases gets a funding boost from the NIH: UAB researchers studying Rett syndrome and tuberous sclerosis among those involved in the national effort.
The discovery could have therapeutic ramifications for conditions including dementia, age-related memory loss or even post-traumatic stress disorder.